AGILVAX INC has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are WORG PHARMACEUTICALS HANGZHOU CO LTD, BIOLOGICAL MIMETICS INC and YU JIANHUA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Pericle Federica | 11 |
#2 | Cavallo Federica | 10 |
#3 | O'Rourke John | 6 |
#4 | O'Rourke John P | 4 |
#5 | Conti Laura | 4 |
#6 | Lanzardo Stefania | 4 |
#7 | Cavallo Frederica | 1 |
#8 | Caldeira Jerri | 1 |
#9 | Salameh Ahmad | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020227640A1 | Compositions and methods related to xct antibodies | |
EP3618869A1 | COMPOSITIONS AND METHODS RELATED TO xCT ANTIBODIES | |
US2018360935A1 | Compositions and methods related to xCT peptides |